Mauna Kea Technologies SAS (MKEA.PA) Key Developments |
United States

Analyst Research

Report Title Price
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : GlobalData
Provider : Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Mauna Kea Technologies SA regulatory clearance from U.S. FDA for New Cellvizio System Functioning in a near Infrared Wavelength

Tuesday, 29 Jul 2014 11:45am EDT 

Mauna Kea Technologies SA:Receives 501(k) regulatory clearance from United States Food and Drug Administration (FDA) (510(k) #K133466) for new Cellvizio system functioning at near-infrared wavelength of 785 nanometers.